NOVO NORDISK A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 918.50 DKK | +0.47% |
|
+4.20% | +31.57% |
| 09-13 | Eli Lilly invests $1.8 billion in Ireland sites to scale up Alzheimer's, obesity drug production | RE |
| 09-12 | NOVO NORDISK : Deutsche Bank keeps its Buy rating | ZD |
Chart calendar Novo Nordisk A/S
8d1516cc9bd63ef039.UQGCTMmdKGw4I4fqa9WacUhl2yJTatBHjBHa_HdNWIE.Pne0PvnxTBlLUreTGZjLAXEJvkk-IYoU_kS-uDEPKNZmbbU9odxyOXlatw~c32d24ab0c1a6bc5cca8bd469ed09a43
Upcoming events on Novo Nordisk A/S
Past events on Novo Nordisk A/S
| 14/08/2024 | Détachement de for dividende intermédiaire |
| 08/08/2024 11:15 | Q2 2024 Earnings Call - London |
| 07/08/2024 12:00 | Q2 2024 Earnings Call |
| 07/08/2024 06:30 | Q2 2024 Earnings Release |
| 24/06/2024 18:30 | American Diabetes Association Scientific Conference |
| 23/06/2024 21:30 | American Diabetes Association Scientific Symposium |
| 22/06/2024 13:00 | American Diabetes Association Scientific Symposium |
| 03/05/2024 13:15 | Q1 2024 Earnings Call - London |
| 02/05/2024 12:00 | Q1 2024 Earnings Call |
| 02/05/2024 06:30 | Q1 2024 Earnings Release |
| 21/03/2024 | Final dividend |
| 21/03/2024 13:00 | Annual General Meeting |
| 07/03/2024 08:00 | Capital Markets Day |
| 01/02/2024 13:15 | Q4 2023 Earnings Call - London |
| 31/01/2024 12:00 | Q4 2023 Earnings Call |
| 31/01/2024 06:30 | Q4 2023 Earnings Release |
| 09/01/2024 17:45 | JPMorgan Healthcare Conference |
| 11/11/2023 23:00 | R&D Day |
| 03/11/2023 13:15 | Q3 2023 Earnings Call - London |
| 02/11/2023 12:00 | Q3 2023 Earnings Call |
Past dividends on Novo Nordisk A/S
| 14/08/2024 | Interim Payment 3.5 DKK |
| 21/03/2024 | Final Payment 6.4 DKK |
| 17/08/2023 | Interim Payment 6 DKK |
| 23/03/2023 | Final Payment 8.15 DKK |
| 11/08/2022 | Interim Payment 4.25 DKK |
| 24/03/2022 | Final Payment 6.9 DKK |
| 15/08/2021 | Interim Payment 3.5 DKK |
| 25/03/2021 | Final Payment 5.85 DKK |
| 13/08/2020 | Interim Payment 3.25 DKK |
| 26/03/2020 | Final Payment 5.35 DKK |
| 15/08/2019 | Interim Payment 3 DKK |
| 21/03/2019 | Final Payment 5.15 DKK |
| 16/08/2018 | Interim Payment 3 DKK |
| 22/03/2018 | Final Payment 4.85 DKK |
| 17/08/2017 | Interim Payment 3 DKK |
| 23/03/2017 | Final Payment 4.6 DKK |
| 11/08/2016 | Interim Payment 3 DKK |
| 20/03/2016 | Annual 6.4 DKK |
| 19/03/2015 | 5 DKK |
| 20/03/2014 | Annual 4.5 DKK |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
|
Net sales Million DKK | Released Forecast Spread | 140 800 139 863 0.67% | 176 954 175 090 1.06% | 232 261 228 920 1.46% | 290 081 | 348 988 | 405 888 |
|
EBITDA Million DKK | Released Forecast Spread | 64 669 65 263 -0.91% | 82 171 82 386 -0.26% | 111 987 109 530 2.24% | 142 456 | 176 414 | 207 955 |
|
EBIT Million DKK | Released Forecast Spread | 58 644 59 273 -1.06% | 74 809 75 141 -0.44% | 102 574 101 255 1.3% | 128 373 | 161 428 | 189 856 |
|
Earnings before Tax (EBT) Million DKK | Released Forecast Spread | 59 080 59 575 -0.83% | 69 062 69 370 -0.44% | 104 674 102 184 2.44% | 127 536 | 159 134 | 187 450 |
|
Net income Million DKK | Released Forecast Spread | 47 757 47 534 0.47% | 55 525 54 785 1.35% | 83 683 82 021 2.03% | 101 797 | 127 816 | 149 148 |
|
EPS DKK | Released Forecast Spread | 10,4 10,3 0.35% | 12,2 12,2 0.25% | 18,6 18,3 1.79% | 22,7 | 28,9 | 34,4 |
| Announcement Date | 02/02/22 | 01/02/23 | 31/01/24 | - |
Quarterly results
| Fiscal Period | June | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million DKK | Released Forecast Spread | 45 566 44 493 2.41% | 48 092 47 116 2.07% | 53 367 52 192 2.25% | 54 300 55 820 -2.72% | 58 731 57 395 2.33% | 65 863 61 207 7.61% | 65 349 63 573 2.79% | 68 060 68 563 -0.73% | 73 628 | 82 374 | 80 556 | 81 139 | 83 849 | 83 805 |
|
EBITDA Million DKK | Released Forecast Spread | 22 225 20 889 6.4% | 19 122 19 770 -3.28% | 26 726 25 825 3.49% | 26 065 26 770 -2.64% | 29 438 27 843 5.73% | 29 758 27 194 9.43% | 34 760 31 300 11.05% | 34 779 29 430 18.17% | 36 994 | 36 969 | 40 004 | 46 240 | 41 093 | |
|
EBIT Million DKK | Released Forecast Spread | 20 184 19 230 4.96% | 17 087 18 221 -6.22% | 25 007 23 950 4.41% | 23 888 25 252 -5.4% | 26 913 25 565 5.27% | 26 766 25 489 5.01% | 31 846 28 694 10.99% | 25 934 27 258 -4.86% | 33 955 | 35 226 | 36 697 | 39 498 | 38 669 | |
|
Earnings before Tax (EBT) Million DKK | Released Forecast Spread | 18 032 17 570 2.63% | 16 316 16 547 -1.4% | 24 737 24 538 0.81% | 24 254 26 344 -7.93% | 28 063 26 623 5.41% | 27 620 25 972 6.34% | 31 918 28 630 11.48% | 25 332 27 740 -8.68% | 33 358 | 35 941 | 36 275 | 39 064 | 36 068 | |
|
Net income Million DKK | Released Forecast Spread | 14 405 14 040 2.6% | 13 592 13 152 3.35% | 19 814 19 606 1.06% | 19 428 20 692 -6.11% | 22 478 21 592 4.1% | 21 963 20 717 6.01% | 25 407 23 169 9.66% | 20 050 22 116 -9.34% | 26 793 | 28 538 | 29 367 | 29 622 | 29 617 | 27 286 |
|
EPS DKK | Released Forecast Spread | 3,17 3,11 1.99% | 3,01 2,93 2.74% | 4,39 4,37 0.36% | 4,32 4,62 -6.59% | 5,00 4,50 11.05% | 4,91 4,59 7.08% | 5,68 5,19 9.54% | 4,49 4,71 -4.72% | 6,04 | 6,44 | 6,61 | 6,67 | 6,68 | 6,15 |
| Announcement Date | 02/11/22 | 01/02/23 | 04/05/23 | 10/08/23 | 02/11/23 | 31/01/24 | 02/05/24 | 07/08/24 | - | - | - | - | - | - |
More events
Past sector events for Novo Nordisk A/S
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NOVO B Stock
- Calendar Novo Nordisk A/S
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition